Christina Dold

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.

Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.

Journal: Microbiology spectrum
Published: August 28, 2026

Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB.

Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenB.

Journal: NPJ vaccines
Published: January 13, 2026

Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.

Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice.

Journal: NPJ vaccines
Published: November 19, 2025

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 25, 2025

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 25, 2025

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Journal: Science translational medicine
Published: May 07, 2025

An mRNA vaccine encoding five conserved Group A Streptococcus antigens.

An mRNA vaccine encoding five conserved Group A Streptococcus antigens.

Journal: Nature communications
Published: January 17, 2025

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.

Journal: Vaccine
Published: April 27, 2024

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members.

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members.

Journal: Frontiers in immunology
Published: June 27, 2023

Immune responses to Neisseria gonorrhoeae and implications for vaccine development.

Immune responses to Neisseria gonorrhoeae and implications for vaccine development.

Journal: Frontiers in immunology
Published: June 27, 2023

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Journal: Science translational medicine
Published: June 21, 2023

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.

Journal: Vaccine
Published: February 06, 2023
Showing 1-12 of 70

Last Updated: 09/26/2026